The U.S. Food and Drug Administration (FDA) recently issued a new safety alert regarding the increased risk of Fournier’s gangrene among diabetes patients using Invokana and other drugs in the same class. Fournier’s gangrene is considered to be a rare, but very serious complication of SGLT2 inhibitors. This condition is... Read more »

The makers of Farxiga, Bristol-Myers Squibb and AstraZeneca, are facing at least 18 product liability lawsuits filed in federal courts. These have now been centralized into a multidistrict litigation (MDL) pursuant to an order issued by the U.S. Judicial Panel on Multidistrict Litigation (JPML) issued on April 6, 2017. The... Read more »

A woman that developed ketoacidosis after taking the diabetes drug Invokana has filed a lawsuit against the drug’s manufacturers. Sheryl Desalis is claiming in her complaint that Janssen Pharmaceuticals, Johnson & Johnson and Mitsubishi Tanabe Pharma failed to provide proper warnings about the risks of diabetic ketoacidosis associated with their... Read more »

Metabolic acidosis is a risk associated with Invokana that was recently highlighted in a report by the Institute for Safe Medical Practices (ISMP). Invokana is one of the drugs recently touted for its ability to manage type 2 diabetes, but potential side effects have raised concerns and led to a... Read more »

The FDA has issued a safety communication involving potentially dangerous side effects associated with a category of type 2 diabetes drugs known as SGLT2 inhibitors. The agency has warned that use of the drug could lead to ketoacidosis, a serious condition often requiring emergency medical care. Urinary tract infections or... Read more »

Anthony R. Allen has filed a lawsuit against Johnson & Johnson and Mitsubishi Tanabe Pharm Corp. He claims that the defendants’ prescription medication, Invokana, resulted in serious injuries that could have claimed his life. Allen is an Illinois resident who began using Invokana in December of 2014. The plaintiff’s Invokana... Read more »

Plaintiff Gene Schurman, a resident of Illinois, claims he suffered severe kidney damage after taking the diabetes drug Invokana under the direction of his doctor. He is now suing Janssen Pharmaceuticals, Johnson & Johnson and Mitsubishi Tanabe Pharma Corporation on claims of failure to warn, product liability, design defect, fraud,... Read more »

As concern over risks associated with the type 2 diabetes drug Invokana continues to rise, a new study has shown the same dangers seen with the drug in type 2 diabetes patients may also be present in those with type 1 diabetes. Researchers have found that off-label use of this... Read more »

London-based AstraZeneca failed to obtain FDA approval for a proposed diabetes drug that combines two different medications, saxagliptin and dapagliflozin. In October 2015, the FDA issued a complete response letter to the pharmaceutical giant’s application. The agency requested additional clinical research on the proposed combination drug. AstraZeneca recently released statements... Read more »

Known as a sodium-glucose cotransporter-2, the blockbuster diabetes drug Invokana has been flying off the shelves, launching it to the top of the class of drugs also including Farxiga, Jardiance, Xigduo XR and Glyxambi. The drug presents a new and innovative way to treat the presence of glucose in the... Read more »